Patients suing insulin makers over rising prices

FILE - In this April 29, 2012 file photo, a woman diagnosed with diabetes gives herself an injection of insulin at her home in the Los Angeles suburb of Commerce, Calif. (AP Photo/Reed Saxon, File)

FILE - In this April 29, 2012 file photo, a woman diagnosed with diabetes gives herself an injection of insulin at her home in the Los Angeles suburb of Commerce, Calif. (AP Photo/Reed Saxon, File)
Local News
By Katie Wedell
Jan 31, 2017
X

The three largest manufacturers of insulin are accused of conspiring in a price-fixing scheme, driving up the cost of lifesaving drugs for millions of patients, according to a lawsuit filed Monday.

IN-DEPTH REPORT: Our ongoing investigation into rising prescription drug prices

The federal suit filed in Massachusetts accuses drug makers Sanofi, Novo Nordisk and Eli Lilly of raising the list prices of their products “in perfect lock step” for years.

The accusations center on the shadowy rebate system between drug makers and pharmacy benefit managers, which this news outlet has been investigating.

Read more about the lawsuit: Insulin makers accused of price-fixing scheme

More from our investigation:

ExploreConsumers kept in the dark over drug pricing
ExploreWho’s really controlling your drug prices? 5 things to know about PBMs
ExploreDayton man lead plaintiff in drug suit alleging price-gouging
Explore$180,000 price tag for Miami Twp. boy’s life-saving prescription
ExploreWhy different prices at different pharmacies?
In Other News
1
Crime is falling in Dayton, with a major exception: Homicides
2
Dayton bike path project stalled after Norfolk Southern doubles price...
3
Plummer announces Senate bid, setting up primary race between feuding...
4
Dayton Schools to have back-to-school event for families, staff Aug. 2
5
What we know now: Dayton police continue to investigate after...

About the Author

Katie Wedell